Tempest Therapeutics IncNASDAQ:TPST
- LAST PRICE0.9404
- TODAY'S CHANGE (%)0.0253 (2.7647%)
- Bid / Lots0.9404/ 10
- Ask / Lots0.9500/ 3
- Open / Previous Close0.9290 / 0.9151
- Day Range
- 52 Week Range
- Volume1,189,773
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TPST |
|---|---|---|
| 09:32 ET | 11371 | 0.92 |
| 09:35 ET | 4853 | 0.9225 |
| 09:37 ET | 1680 | 0.912563 |
| 09:39 ET | 9710 | 0.9298 |
| 09:42 ET | 7698 | 0.93 |
| 09:44 ET | 2805 | 0.93 |
| 09:46 ET | 22000 | 0.93 |
| 09:48 ET | 2649 | 0.933501 |
| 09:50 ET | 100 | 0.9335 |
| 09:51 ET | 11705 | 0.94 |
| 09:53 ET | 11183 | 0.95 |
| 09:55 ET | 1194 | 0.945 |
| 09:57 ET | 3971 | 0.9548 |
| 10:00 ET | 28536 | 0.9595 |
| 10:02 ET | 2691 | 0.952452 |
| 10:04 ET | 11158 | 0.9494 |
| 10:06 ET | 600 | 0.9592 |
| 10:08 ET | 2400 | 0.9494 |
| 10:09 ET | 4250 | 0.945 |
| 10:11 ET | 200 | 0.9494 |
| 10:13 ET | 8591 | 0.946 |
| 10:15 ET | 8097 | 0.9399 |
| 10:18 ET | 300 | 0.9398 |
| 10:20 ET | 1800 | 0.9398 |
| 10:22 ET | 800 | 0.9398 |
| 10:24 ET | 4279 | 0.9398 |
| 10:26 ET | 1100 | 0.93675 |
| 10:27 ET | 400 | 0.9396 |
| 10:29 ET | 100 | 0.9396 |
| 10:31 ET | 1235 | 0.9396 |
| 10:33 ET | 350 | 0.9396 |
| 10:36 ET | 8460 | 0.9395 |
| 10:38 ET | 1711 | 0.9395 |
| 10:40 ET | 5182 | 0.9419 |
| 10:42 ET | 2200 | 0.9427 |
| 10:44 ET | 13349 | 0.9401 |
| 10:45 ET | 1666 | 0.9339 |
| 10:47 ET | 12421 | 0.9337 |
| 10:49 ET | 2589 | 0.9374 |
| 10:51 ET | 100 | 0.9402 |
| 10:54 ET | 581 | 0.94 |
| 10:56 ET | 10375 | 0.9338 |
| 10:58 ET | 12824 | 0.935 |
| 11:00 ET | 1111 | 0.936 |
| 11:02 ET | 538 | 0.94 |
| 11:03 ET | 700 | 0.9412 |
| 11:05 ET | 800 | 0.9474 |
| 11:07 ET | 400 | 0.9473 |
| 11:09 ET | 200 | 0.9474 |
| 11:12 ET | 5489 | 0.949 |
| 11:14 ET | 8271 | 0.9468 |
| 11:16 ET | 100 | 0.9417 |
| 11:18 ET | 4980 | 0.9441 |
| 11:20 ET | 8430 | 0.9401 |
| 11:21 ET | 31303 | 0.9401 |
| 11:23 ET | 1040 | 0.949 |
| 11:25 ET | 200 | 0.949 |
| 11:27 ET | 5600 | 0.949 |
| 11:30 ET | 1958 | 0.9499 |
| 11:32 ET | 400 | 0.9499 |
| 11:34 ET | 8150 | 0.955 |
| 11:36 ET | 868 | 0.959699 |
| 11:38 ET | 9150 | 0.9597 |
| 11:39 ET | 7829 | 0.9597 |
| 11:41 ET | 945 | 0.9597 |
| 11:43 ET | 3801 | 0.9597 |
| 11:45 ET | 3547 | 0.9563 |
| 11:48 ET | 4200 | 0.9563 |
| 11:50 ET | 5389 | 0.9597 |
| 11:52 ET | 700 | 0.9597 |
| 11:54 ET | 1814 | 0.9565 |
| 11:56 ET | 2710 | 0.9597 |
| 11:57 ET | 1307 | 0.9583 |
| 11:59 ET | 6533 | 0.96 |
| 12:01 ET | 86419 | 0.956688 |
| 12:03 ET | 2530 | 0.964 |
| 12:06 ET | 765 | 0.9691 |
| 12:08 ET | 13469 | 0.9609 |
| 12:10 ET | 13600 | 0.9691 |
| 12:12 ET | 2951 | 0.9691 |
| 12:14 ET | 8435 | 0.972549 |
| 12:15 ET | 27999 | 0.9752 |
| 12:17 ET | 7232 | 0.976159 |
| 12:19 ET | 5189 | 0.978 |
| 12:21 ET | 7809 | 0.9701 |
| 12:24 ET | 5505 | 0.98 |
| 12:26 ET | 1135 | 0.9822 |
| 12:28 ET | 5048 | 0.98 |
| 12:30 ET | 35914 | 0.98 |
| 12:32 ET | 1000 | 0.98 |
| 12:33 ET | 2084 | 0.98 |
| 12:35 ET | 2200 | 0.9815 |
| 12:37 ET | 40502 | 0.9749 |
| 12:39 ET | 12000 | 0.98 |
| 12:42 ET | 400 | 0.9799 |
| 12:44 ET | 300 | 0.9799 |
| 12:46 ET | 1718 | 0.9786 |
| 12:48 ET | 2533 | 0.9786 |
| 12:50 ET | 6670 | 0.978 |
| 12:51 ET | 630 | 0.978 |
| 12:53 ET | 4067 | 0.978 |
| 12:55 ET | 400 | 0.978 |
| 12:57 ET | 300 | 0.9718 |
| 01:00 ET | 1900 | 0.97 |
| 01:02 ET | 400 | 0.9656 |
| 01:04 ET | 600 | 0.97 |
| 01:06 ET | 449 | 0.97 |
| 01:08 ET | 26527 | 0.9495 |
| 01:09 ET | 1675 | 0.9425 |
| 01:11 ET | 2846 | 0.94755 |
| 01:13 ET | 1200 | 0.9525 |
| 01:15 ET | 10049 | 0.9532 |
| 01:18 ET | 26007 | 0.96 |
| 01:20 ET | 715 | 0.96 |
| 01:22 ET | 2300 | 0.955049 |
| 01:24 ET | 500 | 0.9589 |
| 01:26 ET | 2300 | 0.9502 |
| 01:27 ET | 300 | 0.9587 |
| 01:29 ET | 26500 | 0.9501 |
| 01:31 ET | 512 | 0.9599 |
| 01:33 ET | 1999 | 0.95 |
| 01:38 ET | 12985 | 0.9462 |
| 01:40 ET | 30722 | 0.95 |
| 01:42 ET | 1360 | 0.9589 |
| 01:44 ET | 3066 | 0.9501 |
| 01:45 ET | 900 | 0.9589 |
| 01:47 ET | 600 | 0.9589 |
| 01:49 ET | 400 | 0.959 |
| 01:51 ET | 735 | 0.959 |
| 01:54 ET | 300 | 0.959 |
| 01:56 ET | 200 | 0.959 |
| 01:58 ET | 11580 | 0.9571 |
| 02:00 ET | 1609 | 0.952 |
| 02:02 ET | 25480 | 0.95655 |
| 02:03 ET | 2142 | 0.9599 |
| 02:05 ET | 21575 | 0.9559 |
| 02:09 ET | 21046 | 0.9476 |
| 02:12 ET | 211 | 0.956 |
| 02:14 ET | 900 | 0.956 |
| 02:16 ET | 3000 | 0.956 |
| 02:18 ET | 500 | 0.956 |
| 02:20 ET | 1396 | 0.9555 |
| 02:21 ET | 500 | 0.9556 |
| 02:23 ET | 3491 | 0.9475 |
| 02:25 ET | 1200 | 0.948 |
| 02:27 ET | 100 | 0.948 |
| 02:30 ET | 700 | 0.948 |
| 02:32 ET | 200 | 0.948 |
| 02:34 ET | 27478 | 0.9478 |
| 02:36 ET | 200 | 0.9478 |
| 02:39 ET | 200 | 0.9474 |
| 02:41 ET | 200 | 0.9477 |
| 02:43 ET | 950 | 0.9478 |
| 02:45 ET | 700 | 0.945 |
| 02:50 ET | 200 | 0.9479 |
| 02:52 ET | 300 | 0.945 |
| 02:54 ET | 1445 | 0.943 |
| 02:57 ET | 4505 | 0.9411 |
| 02:59 ET | 5750 | 0.9448 |
| 03:01 ET | 800 | 0.9352 |
| 03:03 ET | 1100 | 0.9449 |
| 03:08 ET | 400 | 0.9448 |
| 03:10 ET | 2066 | 0.9448 |
| 03:14 ET | 1620 | 0.9448 |
| 03:17 ET | 3101 | 0.9363 |
| 03:19 ET | 1200 | 0.9448 |
| 03:21 ET | 100 | 0.94 |
| 03:24 ET | 700 | 0.9399 |
| 03:26 ET | 1858 | 0.9353 |
| 03:28 ET | 2108 | 0.935301 |
| 03:30 ET | 607 | 0.935301 |
| 03:32 ET | 500 | 0.9399 |
| 03:33 ET | 303 | 0.9399 |
| 03:35 ET | 530 | 0.9399 |
| 03:37 ET | 700 | 0.9449 |
| 03:39 ET | 350 | 0.9448 |
| 03:42 ET | 53692 | 0.9447 |
| 03:46 ET | 100 | 0.9445 |
| 03:48 ET | 2893 | 0.9445 |
| 03:50 ET | 500 | 0.9445 |
| 03:51 ET | 11287 | 0.9354 |
| 03:53 ET | 28985 | 0.9354 |
| 03:55 ET | 1780 | 0.9408 |
| 03:57 ET | 3106 | 0.937 |
| 04:00 ET | 12033 | 0.9404 |
Yesterday
Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference, from 4:30PM ET on Monday Nov 25, 2024 by Dow Jones
4:30PM ET on Monday Nov 25, 2024 by Dow Jones
Nov 13, 2024
DJ Tempest Therapeutics Is Maintained at Overweight by Piper Sandler, from 12:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
12:00PM ET on Wednesday Nov 13, 2024 by Dow JonesDJ Tempest Therapeutics Price Target Maintained With a $47.00/Share by HC Wainwright & Co., from 7:35AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:35AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
Press Release: Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update, from 4:21PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:21PM ET on Tuesday Nov 12, 2024 by Dow JonesTempest Reports Third Quarter 2024 Financial Results and Provides Business Update, from 4:21PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:21PM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tempest Therapeutics Inc | 39.5M | -0.6x | --- |
Xilio Therapeutics Inc | 39.2M | -0.6x | --- |
Exicure Inc | 39.9M | -12.3x | --- |
AN2 Therapeutics Inc | 40.0M | -0.7x | --- |
Intensity Therapeutics Inc | 39.0M | -2.3x | --- |
Reviva Pharmaceuticals Holdings, Inc. | 38.1M | -1.0x | --- |
Company Information
Tempest Therapeutics, Inc. is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a range of tumors. Its two clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495. TPST-1120 is a selective antagonist of peroxisome proliferator-activated receptor alpha (PPAR). The ongoing global randomized Phase Ib/II trial of TPST-1120 combined with the standard-of-care first-line regimen of atezolizumab and bevacizumab in patients with advanced or metastatic hepatocellular carcinoma (HCC). The Company’s second clinical program, TPST-1495, a dual antagonist of the EP2 and EP4 receptors of prostaglandin E2, is in an ongoing Phase I combination trial in patients with endometrial cancer.
Contact Information
- Headquarters
- 2000 SIERRA POINT PARKWAY, SUITE 400BRISBANE, CA, United States 94005
- Phone
- 415-798-8589
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Michael Raab
- President, Chief Executive Officer, Director
- Stephen Brady
- Executive Vice President, Chief Medical Officer
- Samuel Whiting
- Vice President - Strategy and Finance, Corporate Secretary
- Nicholas Maestas
- Vice President - Regulatory Affairs
- Sheldon Mullins
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $39.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 43.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.77 |
EPS | $-1.57 |
Book Value | $1.21 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
